Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesis
- 10 June 2020
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 117 (25) , 14421-14432
Abstract
Epstein-Barr virus (EBV) is a B cell transforming virus that causes B cell malignancies under conditions of immune suppression. EBV orchestrates B cell transformation through its latent membrane proteins (LMPs) and Epstein-Barr nuclear antigens (EBNAs). We here identify secondary mutations in mouse B cell lymphomas induced by LMP1, to predict and identify key functions of other EBV genes during transformation. We find aberrant activation of early B cell factor 1 (EBF1) to promote transformation of LMP1-expressing B cells by inhibiting their differentiation to plasma cells. EBV EBNA3A phenocopies EBF1 activities in LMP1-expressing B cells, promoting transformation while inhibiting differentiation. In cells expressing LMP1 together with LMP2A, EBNA3A only promotes lymphomagenesis when the EBNA2 target Myc is also overexpressed. Collectively, our data support a model where proproliferative activities of LMP1, LMP2A, and EBNA2 in combination with EBNA3A-mediated inhibition of terminal plasma cell differentiation critically control EBV-mediated B cell lymphomagenesis.Keywords
Funding Information
- EC | FP7 | FP7 Ideas: European Research Council (268921)
- Helmholtz-Gemeinschaft (HA-305)
- Helmholtz-Gemeinschaft (ZT-0027)
- RCUK | Medical Research Council (MR/M008584/1)
This publication has 79 references indexed in Scilit:
- Hodgkin lymphomaJournal of Clinical Investigation, 2012
- Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphomaBlood Cancer Journal, 2012
- Immune Surveillance and Therapy of Lymphomas Driven by Epstein-Barr Virus Protein LMP1 in a Mouse ModelCell, 2012
- Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomasBlood, 2011
- Constitutive Canonical NF-κB Activation Cooperates with Disruption of BLIMP1 in the Pathogenesis of Activated B Cell-like Diffuse Large Cell LymphomaCancer Cell, 2010
- BLIMP1 Is a Tumor Suppressor Gene Frequently Disrupted in Activated B Cell-like Diffuse Large B Cell LymphomaCancer Cell, 2010
- EBV LMP2A affects LMP1-mediated NF-κB signaling and survival of lymphoma cells by regulating TRAF2 expressionBlood, 2008
- Epstein-Barr Virus LMP2A Enhances B-Cell Responses In Vivo and In VitroJournal of Virology, 2006
- Tracking germinal center B cells expressing germ-line immunoglobulin γ1 transcripts by conditional gene targetingProceedings of the National Academy of Sciences, 2006
- Dilated heart failure in transgenic mice expressing the Epstein--Barr virus nuclear antigen-leader proteinJournal of General Virology, 1993